On October 16, Astera Labs, Inc. fell 3.17% in Regular Trading, trading at $293.2475 per share, with turnover of $40.5802 million.
The clearest catalyst cited by recent market coverage is continued pressure after Northland Securities downgraded the stock to market perform from outperform, alongside profit-taking ahead of the company’s third-quarter results due on November 3.
Recent reports show this downgrade has weighed on the shares across overnight, pre-market, after-hours, and regular trading sessions over several consecutive days. While consensus expectations were described as broadly stable, with an average analyst rating of overweight, a mean target price of $416.78, and next-quarter EPS expected at $0.83, the rating cut and broader semiconductor weakness have continued to pressure near-term sentiment.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments